Tegean Capital Management’s AdvisorShares Pure US Cannabis ETF MSOS Stock Holding History

Tegean Capital Management’s Portfolio MSOS Stock Details MSOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-45,000	Closed	-$256K	–	26
2023 Q1	$256K	Hold	45,000	–	–	0.33%	20
2022 Q4	$315K	Buy	+45,000	New	+$463K	1.01%	10

Other funds holding MSOS

Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return

AdvisorShares Investments Bethesda, Maryland $549M AUM 32.58% 1-Year Est. Return

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

AFM

Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

JGC

J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return

LAM

LifePro Asset Management San Diego, California $163M AUM 25.54% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Tegean Capital Management's MSOS Position: Q2 2023 in Review

Tegean Capital Management sold out of AdvisorShares Pure US Cannabis ETF (MSOS) in Q2 2023, closing a stake of 45,000 shares — an estimated $256K sold.

Tegean Capital Management first reported a position in MSOS in Q4 2022 and held it in 2 quarters. The position peaked at $315K in Q4 2022. 166 funds tracked by Wall St. Rank hold MSOS as of Q2 2023.

Tegean Capital Management reported no remaining AdvisorShares Pure US Cannabis ETF position as of Q2 2023 after selling out during the quarter.
Tegean Capital Management sold 45,000 AdvisorShares Pure US Cannabis ETF shares in Q2 2023, an estimated $256K.
Tegean Capital Management first reported a position in AdvisorShares Pure US Cannabis ETF in Q4 2022 and held it in 2 quarters.
Tegean Capital Management's AdvisorShares Pure US Cannabis ETF position peaked at $315K in Q4 2022.
166 funds tracked by Wall St. Rank held AdvisorShares Pure US Cannabis ETF as of Q2 2023.

Based on Tegean Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.